3 ·Filed Apr 24, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
No immediate trading implications. Monitor future Form 4 filings for any actual insider buying or selling activity by Gall or other executives.
Final — all horizons settled through T+60d
TNGX ▲ +6.72% at T+60d
NEUTRAL call ✓ call won +6.72% · α vs SPY +1.95% · entry $26.33 → $28.10
T+1d
-4.52%
call -4.52% · α -4.03%
$25.14
settled 5mo ago
T+5d
-13.75%
call -13.75% · α -14.15%
$22.71
settled 5mo ago
T+20d
-23.89%
call -23.89% · α -28.85%
$20.04
settled 4mo ago
T+60d
+6.72%
call +6.72% · α +1.95%
$28.10
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 and granted a power of attorney to Julie Fogarty to file SEC reports on his behalf, including Forms 3, 4, and 5. This is a routine compliance filing related to insider reporting obligations.
Key Facts
- Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 indicating initial beneficial ownership reporting.
- He granted power of attorney to Julie Fogarty to file Forms 3, 4, and 5, Schedule 13D/G, and amendments on his behalf.
- The filing was made effective as of April 24, 2026, with a report date of April 15, 2026.
- No transaction or change in beneficial ownership was disclosed; this is an administrative filing.
Financial Impact
No financial impact — this is a procedural filing with no disclosed share transactions or ownership changes.
Risk Factors
- None identified — this is a standard regulatory requirement for officers and directors.
- Potential for misinterpretation as a signal, but no material information was conveyed.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-177281 |
| Document: 0001193125-26-177281-index-headers.html | 0001193125-26-177281 |
| Document: 0001193125-26-177281-index.html | 0001193125-26-177281 |
| Document: 0001193125-26-177281.txt | 0001193125-26-177281 |
19 reports for TNGX
63% Hit rate best @ T+60▲ +29.28%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | 8-K | $25.58 $25.20 | ▲ +1.49% | ▲ +1.04% | $23.20 (+9.28%) |
Aug 11, 2026 7w ago | 8-K | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 11, 2026 7w ago | Press Release | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 9, 2026 7w ago | Institutional Cluster | $27.67 $25.29 | ▼ −8.60% | ▼ −8.55% | $23.20 (−16.14%) |
Aug 6, 2026 8w ago | 8-K | $27.07 $25.60 | ▼ −5.43% | ▼ −5.83% | $23.20 (−14.28%) |
Jun 11, 2026 16w ago | 144 | $30.94 $27.97 | ▼ −9.60% | ▼ −10.27% | $23.20 (−25.00%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 424B5 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 144 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Showing 10 of 19
US Market Status
Market Open — Closes in 2h 19m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access